Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02831764
Brief Title: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 2)

First Submitted : July 8, 2016
First Submitted that Met QC Criteria : July 8, 2016
First Posted : July 13, 2016 (Estimate)

Results First Submitted : March 28, 2019
Results First Submitted that Met QC Criteria : March 28, 2019
Results First Posted : April 22, 2019

Last Update Submitted that Met QC Criteria : March 28, 2019
Last Update Posted : April 22, 2019